Canadian Watchdog Suspends Grifols' Plasma Collection License Over Quality Management Concerns

06:15 AM EDT, 09/24/2026 (MT Newswires) -- Canada's health regulator suspended Grifols' (GRF.MC) license to collect plasma at its Taylor Avenue facility in Winnipeg over quality management concerns, local news outlet the Globe and Mail reported Wednesday. The Spanish drugmaker recently faced critical inspections conducted by Health Canada following the deaths of two donors at its facilities, the news report states. Grifols told the publication that the license suspension would not affect its operations as it had already paused plasma collection in the country on Aug. 14. Grifols did not immediately respond to a request for comment from MT Newswires.